Search Results

Endothall 100 mg  | 98.92%

TargetMol

Endothall is a useful organic compound for research related to life sciences. The catalog number is T2747 and the CAS number is 145-73-3.

More Information Supplier Page

Endothall 200 mg  | 98.92%

TargetMol

Endothall is a useful organic compound for research related to life sciences. The catalog number is T2747 and the CAS number is 145-73-3.

More Information Supplier Page

Loganin 25 mg  | Purity Not Available

TargetMol

Loganin, an iridoid glucoside, has been reported to be an inhibitor of Cox-1 and also noted to suppress TNF-α formation. This compound also has displayed potent free-radical-scavenging activity and inhibitory effects on melanogenesis.

More Information Supplier Page

Loganin 100 mg  | Purity Not Available

TargetMol

Loganin, an iridoid glucoside, has been reported to be an inhibitor of Cox-1 and also noted to suppress TNF-α formation. This compound also has displayed potent free-radical-scavenging activity and inhibitory effects on melanogenesis.

More Information Supplier Page

Saikosaponin A 1 mg  | 98.76%

TargetMol

Saikosaponin A has a variety of pharmacological benefits, including antiepileptic, anti-osteoporosis, antioxidant, anti-in ammatory, immunomodulatory, and anti-bacterial activities. It can effectively attenuate neuropathic pain in CCI rats by inhibiting the activation of p38 MAPK and NF-κB signaling pathways in spinal cord. It can inhibit NMDA receptor current and persistent sodium current, and inhibit the TNF-α […]

More Information Supplier Page

Caffeic Acid 100 mg  | 99.30%

TargetMol

Caffeic Acid is an orally bioavailable, hydroxycinnamic acid derivative and polyphenol, with potential anti-oxidant, anti-inflammatory, and antineoplastic activities.

More Information Supplier Page

Puerarin 25 mg  | 99.84%

TargetMol

Puerarin, also known as Kakonein, is a member of the class of compounds known as isoflavonoid C-glycosides. It is a 5-HT2C receptor antagonist.

More Information Supplier Page

MSDC 0160 100 mg  | 99.45%

TargetMol

MSDC-0160 is a prototype mTOT-modulating insulin sensitizer being used in trials studying the treatment of Type 2 Diabetes and Alzheimer’s Disease.

More Information Supplier Page